Hema Seshadri

Consulting/Practice Interests

https://dataworksai.com/
Analytics is transforming the business landscape. All over the world, companies are using data to plan, invent, evolve, and gain critical insight into their customers, markets, and operations. The hype around analytics is well justified. But, as many businesses soon discover, implementing an analytics initiative in practice is no easy task. Most analytics projects never make it to production. Even companies that manage to engineer a workable product prototype can stumble at the last hurdle and fail to realize the benefit of their analytics investment.

How can DataWorksAI Help?
DataWorksAI is a data and analytics consulting company with one driving focus: guiding clients through their organizational analytics transformation. From strategy to execution, we empower businesses to seize the power of data and analytics to uncover business insights and reap the rewards of data-driven decision-making.

Bio

Analytics expert Hema Seshadri, Ph.D., is passionate about using software engineering ingenuity to tap the power of advanced analytics for business. Dr. Seshadri has worked at several leading cloud computing and data analytics companies in the Boston area. While at EMC (now Dell EMC), she designed and developed the first advanced analytics feature in CloudIQ, a cloud analytics software as a service (SaaS) cloud management software product solution. She is currently a senior data scientist at Akamai Technologies, where she develops predictive and prescriptive analytics solutions for global network and data center planning, network optimization, and customer intelligence.
Dr. Seshadri is committed to developing and mentoring the next generation of STEM talent. She teaches at Northeastern University and Bentley University and volunteers in programs such as the Akamai STEM Foundation, Girls Who Code, the MIT Innovation Challenge, and MIT CodeIT. Dr. Seshadri began her career as a biomedical research scientist. She is the co-inventor of a patented cancer drug, Rezurock, licensed and marketed by Sanofi.

Professional Links